Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

PowerPoint Presentation Sukriti Kamboj MD, , Chris Wood, Mahvish Muzaffar MD, Darla Liles MD Hematology Oncology Fellowship East Carolina University, kambojs19@ecu.edu Impact of COVID-19 pandemic on cancer screening in Eastern North Carolina: Experience of rural health network Background: As COVID-19 pandemic was ravaging through United States (US) in early spring, …
Slide 1 Aim Background RESULTS DISCUSSION Limitations References Peripheral Blood T cell responses to immunotherapy related adverse events in NSCLC patients treated with Immunotherapy Suneetha Amara, Mahvish Muzaffar, Li Yang Department off Hematology and Oncology East Carolina University Greenville, North Carolina 27858 amaras19@ecu.edu MATERIALS & METHODS …
PowerPoint Presentation Acute Myeloid Leukemia Patients in Complete Remission with Positive Measurable Residual Disease Prior to Allogeneic Transplant Have Worse Outcomes, Similar to Active Disease Regardless of Conditioning Regimen Intensity and Post-Transplant Cyclophosphamide Administration Pavan Tenneti, MD , Jiaxian He, MS , Brittany Knick Ragon, MD , Nilay A. Shah, MD , Jing Ai, …
Daniel Margalski, DO, Department of Internal Medicine, Wake Forest School of Medicine, Thomas Lycan Jr., DO, Department of Hematology & Oncology, Wake Forest School of Medicine, Suraj Rajendran, Department of Biomedical Engineering, Georgia Institute of Technology, Umit Topaloglu, PhD, Department of Cancer Biology, Wake Forest School of Medicine Machine learning for prospective identification …
In 2021, ACCC launched the ACCC Community Oncology Research Institute (ACORI), which builds on ACCC’s mission to achieve equitable cancer care for all patients by forming key community partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event held September 13-14, 2021, to garner participant feedback and guide the future of the institute.
Suneetha Amara et al., East Carolina University, Greenville, NC View Poster
The Mangled Extremity From Action to Impact: Improving Breast Cancer Care in North Carolina A cohort of 26,482 breast cancer (stages I-III) patients diagnosed in North Carolina between 2004- 2015 from the Carolina Information and Population Health Resource (CIPHR) was created. Time to treatment (TTx) was defined as number of days between diagnosis and first claim for cancer- directed …
Slide 1 • Before 2017 patients with unresectable stage III non-small cell lung cancer (NSCLC) received definitive chemoradiation without maintenance therapy. • Immunotherapy, including immune checkpoint inhibition with durvalumab, represents a major therapeutic breakthrough in cancer and has changed clinical practice in the treatment of NSCLC. • The PACIFIC trial ushered …
October 4, 2021
Join us at the virtual Multidisciplinary Summit on Treating Advanced Prostate Cancer in the Community Setting on Monday, October 4, 2021. Open to all members on the cancer care team, the Summit will explore practical solutions to improve the care of patients with advanced prostate cancer. We'll identify barriers to shared decision-making and propose new ways to better educate patients about their about …
Comprehensive Care of Patients with Advanced Prostate Cancer through Shared Decision-Making LANDSCAPE ANALYSIS ASSOCIATION OF COMMUNITY CANCER CENTERS TABLE OF CONTENTS Background 1 Current Treatment Landscape for Prostate Cancer 2 Tips to Achieve Shared Decision-Making 3 Consider Health Disparities 6 The Impact of COVID-19 on Care Decisions 7 Conclusion 8 References 8 Acknowledgments …
October 1, 2021
The landscape of cancer care is rapidly evolving, and oncology pathways play a critical role in defining how we treat our patients. This meeting, which is the official congress of the Journal of Clinical Pathways, serves as a forum for those involved in all stages of the pathway development process to ask questions, learn how to measure outcomes, and explore ways to partner and expand pathway …
Although clinical trials have been used for decades to determine the safety and efficacy of drugs and medical devices, the lack of a diverse population in such studies has failed to represent the population suffering the burden of the diseases being studied.
The field of oncology is increasingly adopting a precision medicine approach in which biomarkers are used to guide care management.1 A biomarker is defined by the U.S. Food and Drug Administration (FDA) as “a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or biological responses to an exposure or intervention, including therapeutic …
PowerPoint Presentation A Multidisciplinary Consortium to Advance Genetic Counseling in Oncology Lunch and Learn #2 September 28, 2021 Introductions: Staff Limaya Atembina, MSW Program Manager, Provider Education Association of Community Cancer Centers (ACCC) Lu Anne Bankert, CAE Executive Director, Iowa Oncology Society Oncology State Societies at ACCC Joseph …
September 29, 2021
This webinar will focus on the challenges facing ethnic and racial minorities, impoverished people and sexual and gender minorities (LGBTQ) and options available to clinicians to improve these patients access to comprehensive biomarker testing and precision medicines.
To help cancer programs and practices establish and maintain robust financial navigation programs, ACCC's Financial Advocacy Network recently developed the “Ready, Set, Go! Financial Advocacy Playbook” for all members of the cancer care team—particularly those who provide any level of financial advocacy services.
One serious, unwanted side effect of the COVID-19 pandemic is the potential for substantial consequences for cancer outcomes due to delayed access to cancer diagnosis and treatment. Hear from Dr. Debra Patt, the author of a study which detected a substantial decrease (among American seniors) in cancer screenings, visits, therapy, and surgeries.
Research topics include identifying health disparities in precision medicine, delivery of quality advanced ovarian and non-small cell lung (NSCLC) cancer care, programmatic evaluation of geriatric cancer care, and the creation of a self-guided training program for oncology financial advocates.
2021 ACCC Innovator Awards: Integrating Community Paramedics into the Cancer Care Team July 8, 2021 Effectively managing oncology patients’ treatment-related symptoms is a challenge many cancer programs and practices face. To prevent patients with cancer from having to access the emergency department (ED) or hospital throughout treatment, oncology providers want to be able to provide timely care …
Despite the havoc it has caused, our continuously unfolding public health emergency has given us hope that some elusive policy initiatives are now not the stretch they once were.